Carnovas HZ Tablet 5 mg+12.5 mg is a fixed-dose combination of Nebivolol and Hydrochlorothiazide, formulated for the effective management of hypertension (high blood pressure). This combination brings together two complementary mechanisms of action to achieve better blood pressure control than monotherapy, particularly in patients who do not respond adequately to a single antihypertensive agent.
Nebivolol is a highly selective beta-1 adrenergic receptor blocker with additional vasodilatory properties. It lowers blood pressure by reducing heart rate, myocardial contractility, and cardiac output, while also promoting nitric oxide–mediated vasodilation. This results in improved blood vessel relaxation and enhanced peripheral circulation.
Hydrochlorothiazide is a thiazide diuretic that works by increasing the excretion of sodium and water through the kidneys. By reducing plasma volume and peripheral resistance, it effectively lowers blood pressure and helps prevent fluid retention. When combined with Nebivolol, Hydrochlorothiazide enhances the overall antihypertensive effect while allowing lower doses of each component.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Provides dual-action blood pressure control
Combines beta-blockade with diuretic effect
Improves vascular relaxation and blood flow
Helps reduce cardiovascular risk associated with hypertension
Convenient once-daily dosing improves patient compliance
Carnovas HZ Tablet is indicated for:
Essential hypertension
Patients requiring combination therapy for optimal blood pressure control
Reduction of hypertension-related cardiovascular complications when used as prescribed
This formulation is particularly useful when monotherapy with either agent alone is insufficient.
The usual recommended dose is one tablet once daily, or as directed by a physician. It should be taken at the same time each day, preferably in the morning. The tablet should be swallowed whole with water and may be taken with or without food. Dose adjustments depend on individual patient response and clinical condition.
Use with caution in patients with renal or hepatic impairment
Monitor electrolytes regularly due to the diuretic component
Caution is advised in patients with diabetes, gout, asthma, or conduction disorders
Abrupt discontinuation should be avoided without medical advice
Not recommended during pregnancy and breastfeeding unless clearly necessary
Some patients may experience:
Dizziness or fatigue
Headache
Increased urination, especially at the start of therapy
Electrolyte imbalance
Slow heart rate
Most side effects are mild and transient. Persistent or severe symptoms should be reported to a healthcare professional.
Store below 30°C in a cool, dry place, protected from light and moisture. Keep out of reach of children.
Carnovas HZ Tablet 5 mg+12.5 mg (Nebivolol + Hydrochlorothiazide) offers an effective and well-balanced combination therapy for hypertension. By addressing blood pressure through complementary mechanisms, it provides reliable control, improved compliance, and long-term cardiovascular protection when used under proper medical supervision.
Login Or Registerto submit your questions to seller
No none asked to seller yet